title: Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000.
authors.affiliation: Duke Clinical Research Institute, Durham, NC, USA.
authors.forename: D K
authors.initials: DK
authors.lastname: McGuire
authors.forename: J C
authors.initials: JC
authors.lastname: O'shea
authors.forename: C K
authors.initials: CK
authors.lastname: Dyke
authors.forename: D E
authors.initials: DE
authors.lastname: Kandzari
authors.forename: M A
authors.initials: MA
authors.lastname: East
authors.forename: T R
authors.initials: TR
authors.lastname: Tolleson
mesh_terms: D044383:Black People; D002309:Cardiology; D002318:Cardiovascular Diseases / Q000628:therapy*; D002986:Clinical Trials as Topic; D000077542:Eptifibatide; D006333:Heart Failure / Q000208:ethnology / Q000401:mortality; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy; D009204:Myocardial Revascularization; D010455:Peptides / Q000008:administration & dosage*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D012955:Societies, Medical; D015607:Stents; D015996:Survival Rate; D014481:United States; D001741:Black or African American
chemical_list: D010455:Peptides; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077542:Eptifibatide